NYSE MKT AMEX
(
- developing compounds to decrease inflammation, receives FDA's Special Protocol Assessment and starts 2nd Phase III pivotal trial of Ampion
(
- drugs for inflammatory and cancer diseases, to issue 2M+ shares at $4.35 per ADS; FDA grants Fast Track to CF102 to treat liver cancer
(
- medical device co. using robotics to improve minimally invasive surgery, rings NYSE opening bell; acquires ALF-X surgical robotic system
NASDAQ
(
- largest U.S. Burger King franchisee with 661 restaurants, Aug. 7 completes acquisition of five Burger Kings in South Carolina; strong Q2
TSX Venture (quote V. and ticker symbol)
(
- scalable cloud-based video production solutions, expands (
(
- high-grade gold producer with its own mill and 4-Quebec plus 1-Ontario properties, intersects 10.1 g/t Au over 26.2 meters near surface
Sign-up at InvestorsGuru.com (or blog.InvestorsGuru.com) for our Small Cap Stock Observer newsletter, and to set-up your own My Portfolio, My Watchlist & Alerts and News by Email preferences, or quote to comment at our AnyTicker.com Bulletin Boards. Free!
No comments:
Post a Comment